Get the Stockscreener App
1.05
1.87%
-0.02
After Hours:
1.01
-0.04
-3.81%
Lite Strategy Inc stock is traded at $1.05, with a volume of 856.46K.
It is down -1.87% in the last 24 hours and down -11.02% over the past month.
Lite Strategy Inc is focused on the clinical development of novel therapies for cancer. The company's portfolio of drug candidates includes voruciclib, an oral cyclin-dependent kinase 9 (CDK9) inhibitor and zandelisib, an oral, once-daily, selective PI3K inhibitor. It is a clinical-stage pharmaceutical company committed to the development of novel and differentiated cancer therapies intended to improve outcomes for patients.
See More
Previous Close:
$1.07
Open:
$1.09
24h Volume:
856.46K
Relative Volume:
2.72
Market Cap:
$35.73M
Revenue:
$65.30M
Net Income/Loss:
$-39.70M
P/E Ratio:
-0.6044
EPS:
-1.7372
Net Cash Flow:
$-12.17M
1W Performance:
-3.67%
1M Performance:
-11.02%
6M Performance:
-45.31%
1Y Performance:
+0.00%
1-Day Range:
$0.97
$1.12
1-Week Range:
$0.97
$1.14
52-Week Range:
$0.951
$3.03
Lite Strategy Inc Stock (LITS) Company Profile
Name
Lite Strategy Inc
Sector
Industry
Phone
858-369-7100
Address
9920 PACIFIC HEIGHTS BLVD, SAN DIEGO
Compare LITS vs VRTX, REGN, ARGX, ALNY, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LITS
Lite Strategy Inc
|
1.05 | 36.41M | 65.30M | -39.70M | -12.17M | -1.7372 |
VRTX
Vertex Pharmaceuticals Inc
|
435.93 | 110.28B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
634.62 | 66.98B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
808.43 | 50.15B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
295.50 | 39.71B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
154.89 | 32.22B | 742.00K | -1.37B | -1.07B | -7.0731 |
Lite Strategy Inc Stock (LITS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-23-24 | Downgrade | Laidlaw | Buy → Hold |
| Mar-25-22 | Downgrade | Jefferies | Buy → Hold |
| Mar-25-22 | Downgrade | Stifel | Buy → Hold |
| Mar-25-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Feb-03-22 | Initiated | Jefferies | Buy |
| Sep-22-20 | Initiated | Alliance Global Partners | Buy |
| May-29-20 | Initiated | SunTrust | Buy |
| Dec-20-18 | Initiated | H.C. Wainwright | Buy |
| Jul-27-18 | Upgrade | Stifel | Hold → Buy |
| Jul-13-18 | Initiated | SunTrust | Buy |
| Apr-18-16 | Reiterated | Wedbush | Neutral |
| Mar-23-15 | Downgrade | ROTH Capital | Buy → Neutral |
| Dec-18-14 | Reiterated | ROTH Capital | Buy |
| Oct-16-14 | Reiterated | ROTH Capital | Buy |
| Jul-08-14 | Resumed | Brean Capital | Buy |
| Oct-22-13 | Reiterated | Stifel | Buy |
| Apr-15-13 | Initiated | Stifel | Buy |
View All
Lite Strategy Inc Stock (LITS) Latest News
MSN Money - MSN
Lite Strategy Inc. (LITS) Slides 2.73% as Selling Pressure Mounts Near Key SupportFactor Rotation - Newser
Lite Strategy Inc. (LITS) Q4 2024 Earnings: Significant EPS Miss Amid Strategic ChallengesLong-Term Guidance - Newser
LITS Q4 2024 Earnings: Significant EPS Miss Raises Concerns Amid Lack of Revenue DisclosureShared Momentum Picks - Newser
Lite Strategy Inc. (LITS) Q4 2024 Earnings: EPS Misses Estimates by Wide Margin, Stock DeclinesOperating Income Trends - Newser
Top Lite Strategy (LITS) Competitors 2026 - MarketBeat
Lite Strategy Inc. (LITS) Q4 2024 Earnings: Significant EPS Miss Signals Operational ChallengesEarnings Revision Report - Newser
Lumentum Vs. Coherent: Why LITE Is The Superior AI Infrastructure Play (NASDAQ:LITE) - Seeking Alpha
Number of shareholders of Lite Strategy, Inc. – NASDAQ:LITS - TradingView
Lite Strategy, Inc. 10-Q Report: Financial Information, Market Risk Disclosures, and Management Analysis for 2026 - Minichart
Lite Strategy (LITS) Q3 FY2026 Earnings: EPS N/A, Revenue N/A -- - GuruFocus
Lite Strategy Reports Q3 2026 Results: Grows Yield on Litecoin Holdings, Expands Share Repurchase Program, and Highlights SEC’s Digital Commodity Guidance 1 - Minichart
Lite Strategy reports continued LTC yield generation and share repurchases - TradingView
Lite Strategy, Inc. 1Q 2026: Net loss $(23.7)M, EPS $(0.66) — 10-Q Summary - TradingView
Lite Strategy (Nasdaq: LITS) ramps up LTC yield strategy and $25M buyback plan - Stock Titan
Lite Strategy, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2026 - marketscreener.com
Crypto-heavy shift at Lite Strategy (Nasdaq: LITS) with $48M in LTC - Stock Titan
Lite Strategy Reports Fiscal 2026 Third Quarter Results - GlobeNewswire
What Lite Strategy (LITS) is doing that could pay off big later (Trend Strengthens) 2026-05-11Crowd Trend Signals - Newser
How Lite Strategy (LITS) compares to the market average (-4.20%) 2026-05-08Breakout Signals - newser.com
Optical Communications Giant Lumentum Posts Strong Results but Shares Plunge in Sell-Off? Suspected Market Overinterpretation - TradingKey
Sallie Mae (SLM) Reports Q1 2026 Financial Results and Highlights Strategic Shift to Asset-Light Growth Model - Minichart
25 Stocks on Jim Cramer’s Radar: Arm, Arista, and CoreWeave - Insider Monkey
Lite Strategy Inc Stock (LITS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.98%
0.12%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):